Robin M Warren Selected Research

Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)

1/2022	A treatment recommender clinical decision support system for personalized medicine: method development and proof-of-concept for drug resistant tuberculosis.
1/2022	Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study.
1/2022	Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosis.
11/2021	Linezolid Population Pharmacokinetics in South African Adults with Drug-Resistant Tuberculosis.
11/2021	Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study.
10/2021	Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa.
9/2021	Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and rifampicin resistance.
1/2021	Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.
11/2020	MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era.
1/2020	Rifampicin Resistant Tuberculosis in Lesotho: Diagnosis, Treatment Initiation and Outcomes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robin M Warren Research Topics

Disease

55	Tuberculosis (Tuberculoses) 01/2022 - 09/2005
26	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 09/2005
20	Infections 03/2022 - 03/2004
12	Extensively Drug-Resistant Tuberculosis 01/2022 - 02/2010
5	Coinfection 10/2019 - 09/2005
4	Reinfection 10/2019 - 08/2005
2	HIV Infections (HIV Infection) 11/2021 - 01/2019
2	Bovine Tuberculosis 11/2019 - 08/2019
1	Disease Progression 01/2022
1	Necrosis 12/2021
1	Pulmonary Tuberculosis 11/2021
1	Extrapulmonary Tuberculosis 01/2018
1	Cough 01/2017
1	Communicable Diseases (Infectious Diseases) 08/2013

Drug/Important Bio-Agent (IBA)

31	Pharmaceutical PreparationsIBA 01/2022 - 08/2005
19	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 09/2010
7	CytokinesIBA 12/2021 - 08/2019
7	GoldIBA 12/2021 - 12/2009
6	Isoniazid (Ftivazide)FDA LinkGeneric 10/2021 - 08/2011
6	Biomarkers (Surrogate Marker)IBA 02/2021 - 12/2014
5	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 05/2012
5	Proteins (Proteins, Gene)FDA Link 06/2020 - 01/2015
4	bedaquiline (R207910)IBA 01/2022 - 01/2016
4	Interferon-gamma (Interferon, gamma)IBA 12/2021 - 08/2010
3	Pyrazinamide FDA LinkGeneric 01/2022 - 01/2013
3	Indicators and Reagents (Reagents)IBA 01/2022 - 08/2012
3	Amikacin (A.M.K)FDA LinkGeneric 01/2022 - 04/2012
3	VaccinesIBA 11/2020 - 12/2013
3	AerosolsIBA 10/2019 - 12/2013
3	Rifabutin (Ansamycin)FDA Link 10/2018 - 01/2013
3	Capreomycin (Capastat)FDA Link 01/2017 - 04/2012
3	Peptides (Polypeptides)IBA 01/2015 - 04/2012
2	AminoglycosidesIBA 01/2022 - 04/2012
2	Ofloxacin (Ofloxacine)FDA LinkGeneric 01/2022 - 07/2011
2	FluoroquinolonesIBA 01/2022 - 06/2017
2	Linezolid (Zyvox)FDA Link 11/2021 - 01/2019
2	ChemokinesIBA 01/2021 - 01/2021
2	AntigensIBA 05/2016 - 07/2014
2	Tuberculin (PPD)IBA 07/2014 - 02/2008
2	Kanamycin FDA Link 01/2013 - 04/2012
2	Ethambutol (Myambutol)FDA LinkGeneric 01/2013 - 01/2012
2	lipoarabinomannan (LAM)IBA 12/2010 - 04/2008
1	Illicit Drugs (Recreational Drugs)IBA 01/2022
1	NucleotidesIBA 01/2022
1	AntibodiesIBA 12/2021
1	Interleukin-1beta (Interleukin 1 beta)IBA 12/2021
1	SilverIBA 01/2021
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 10/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Antitubercular AgentsIBA 01/2019
1	Biological ProductsIBA 01/2018
1	ProteomeIBA 10/2017
1	6-chloropenicillanic acid S-sulfoxideIBA 01/2017
1	Aminosalicylic Acid (Rezipas)FDA Link 01/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2015
1	Adenosine Triphosphate (ATP)IBA 05/2014
1	EnzymesIBA 08/2013
1	Codon (Codons)IBA 01/2013
1	Ethionamide (Trecator-SC)FDA Link 01/2013
1	Streptomycin (Streptomycin Sulfate)FDA Link 01/2013
1	Moxifloxacin (Avelox)FDA Link 05/2012
1	ElementsIBA 11/2009

Therapy/Procedure

7	Therapeutics 11/2018 - 10/2006
2	Drug Therapy (Chemotherapy) 01/2019 - 03/2017
2	Injections 06/2017 - 04/2012
1	Precision Medicine 01/2022
1	Drug Substitution 01/2019
1	Aftercare (After-Treatment) 06/2014
1	Retreatment 03/2004